Back to search

Article

Comprehensive procedure for injecting Evusheld® for hematological diseases in a single institute

2024-01-29

Abstract excerpt

<title>Abstract</title> <p>Tixagevimab and cilgavimab (EVA, Evusheld®), monoclonal antibody combination treatments, consisted of two neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). EVA showed prophylactic and therapeutic effects against coronavirus disease 2019. The Japanese Society of Hematology recommended EVA for such patients with active treatment, but each instit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1bedd858-3441-5b14-825a-e173427a2d1a
DOI
10.21203/rs.3.rs-3875630/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comprehensive procedure for injecting Evusheld® for hematological diseases in a single instituteDOI 10.21203/rs.3.rs-3875630/v1
Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide EvidenceSemantic proximity
Effectiveness of casirivimab and imdevimab, and sotrovimab during Delta variant surge: a prospective cohort study and comparative effectiveness randomized trialSemantic proximity
Therapeutic efficacy of VV116 for follicular lymphoma complicated with COVID-19: A case reportSemantic proximity
Pre-exposure prophylaxis for COVID-19 with Tix-agevimab/Cilgavimab in kidney transplant recipients in the Kraken variant (XBB.1.5) era: A Single-center ExperienceSemantic proximity
Successful Treatment of Convalescent Plasma Therapy in Three Patients With Severe SARS-CoV-2 Infection in Fuzhou, ChinaSemantic proximity
<strong>&shy;&shy;</strong>A Radiation Oncology Departmental Policy for the 2019 Novel Coronavirus (COVID-19) PandemicSemantic proximity
COVID-19 severity in patients with chronic lymphocytic leukemia treated with venetoclax: a single-center observational cohort studySemantic proximity
EFFECTIVENESS OF CASIRIVIMAB-IMDEVIMAB AND SOTROVIMAB MONOCLONAL ANTIBODY TREATMENT AMONG HIGH-RISK PATIENTS WITH SARS-CoV-2 INFECTION: A REAL-WORLD EXPERIENCESemantic proximity
Select a neighboring publication to make it the new centre.